Off-label use of anti-IL-1 drugs in rheumatic diseases

Interleukin-1 (IL-1) plays a key role in the pathogenesis of different rheumatic diseases. There are now several agents available on the market capable of blocking IL-1. The proven effectiveness and excellent safety of these drugs makes them a possible therapeutic option in the treatment of IL-1 dri...

Descripción completa

Detalles Bibliográficos
Autores principales: Stefania, Silvia, Colia, Ripalta, Cinzia, Rotondo, Corrado, Addolorata, Cantatore, Francesco Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056561/
https://www.ncbi.nlm.nih.gov/pubmed/33855881
http://dx.doi.org/10.1177/20587384211006584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056561/
https://www.ncbi.nlm.nih.gov/pubmed/33855881
http://dx.doi.org/10.1177/20587384211006584

Ejemplares similares